首页> 美国卫生研究院文献>World Journal of Gastrointestinal Endoscopy >Endoscopic retrograde cholangiography for pediatric choledocholithiasis: Assessing the need for endoscopic intervention
【2h】

Endoscopic retrograde cholangiography for pediatric choledocholithiasis: Assessing the need for endoscopic intervention

机译:内镜逆行胆管造影术治疗小儿胆总管结石:评估内镜干预的必要性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To assess pediatric patients for choledocholithiasis. We applied current adult guidelines to identify predictive factors in children.METHODS: A single-center retrospective analysis was performed at a tertiary children’s hospital. We evaluated 44 consecutive pediatric patients who underwent endoscopic retrograde cholangiography (ERCP) for suspected choledocholithiasis. Patients were stratified into those with common bile duct stones (CBDS) at ERCP vs those that did not using the American Society of Gastrointestinal Endoscopy (ASGE) guidelines (Very Strong and Strong criteria) for suspected CBDS.RESULTS: CBDS were identified in 84% at the time of ERCP. Abdominal ultrasound identified CBDS in 36% of patients. Conjugated bilirubin ≥ 0.5 mg/dL was an independent risk factor for CBDS (P = 0.003). The Very Strong (59.5%) and Strong (48.6%) ASGE criteria identified the majority of patients (P = 0.0001). A modified score using conjugated bilirubin had a higher sensitivity (81.2% vs 59.5%) and more likely to identify a stone than the standard criteria, odds ratio of 25.7 compared to 8.8. Alanine aminotransferase and gamma-glutamyl transferase values identified significant differences in a subset of patients with odds ratio of 4.1 and 3.25, respectively.CONCLUSION: Current adult guidelines identified the majority of pediatric patients with CBDS, but specific pediatric guidelines may improve detection, thus decreasing risks and unnecessary procedures.
机译:目的:评估儿科患者的胆总管结石症。我们应用了当前的成人指南来确定儿童的预测因素。方法:在一家三级儿童医院进行了单中心回顾性分析。我们评估了44例接受内窥镜逆行胆管造影术(ERCP)的小儿患者的可疑胆总管结石症。与未使用美国胃肠内镜协会(ASGE)指南(非常强和强标准)的可疑CBDS患者相比,ERCP患者被分为胆总管结石(CBDS)患者。结果:在84%的患者中发现了CBDS在ERCP时。腹部超声在36%的患者中识别出CBDS。结合胆红素≥0.5 mg / dL是CBDS的独立危险因素(P = 0.003)。非常强(59.5%)和强(48.6%)ASGE标准确定了大多数患者(P = 0.0001)。使用共轭胆红素的改良评分比标准标准具有更高的敏感性(81.2%比59.5%),并且更有可能识别出结石,比值比为8.8,为25.7。丙氨酸氨基转移酶和γ-谷氨酰转移酶的值分别在比值比为4.1和3.25的部分患者中发现了显着差异。结论:目前的成人指南确定了大多数CBDS的儿科患者,但是具体的儿科指南可能会改善检测,从而降低风险和不必要的程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号